GlassScriptPhysician profile
Ian C Cook
NPI 1154703031
$1,496.22
in general payments reported to CMS, 2019-2025
12 companies · $531 in 2025
The $531 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $193 · 2023: $346 · 2024: $427 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,286 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,285.55 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $220.75 | 2022-2023 | Olympus |
| Abbott Laboratories | $211.32 | 2024-2025 | Diamondback Peripheral, Esprit |
| Intuitive Surgical, INC. | $208.02 | 2023-2024 | Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $176.74 | 2023-2025 | Keytruda, Lynparza |
| Ethicon INC. | $145.08 | 2025 | Monarch Platform |
| Astrazeneca Pharmaceuticals LP | $128.00 | 2023-2025 | Lynparza |
| Abbvie INC. | $122.47 | 2024-2025 | |
| Eisai INC. | $116.85 | 2022-2025 | |
| Immunogen, INC. | $80.05 | 2023 | Elahere |
| Medtronic, INC. | $55.13 | 2022 | |
| Glaxosmithkline, LLC. | $21.06 | 2025 | Zejula, Jemperli |
| On Target Laboratories, INC | $10.75 | 2025 | Cytalux |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.